human hematopoietic stem cells are shielded from CD123-targeted immunotherapy (Cimeio Therapeutics)

N/A

Report date: 2025/09/01 16:35:32

Base Information

Drug Namehuman hematopoietic stem cells are shielded from CD123-targeted immunotherapy (Cimeio Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionInterleukin-3 receptor subunit alpha modulators
TargetsInterleukin-3 receptor subunit alpha
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCimeio Therapeutics AG
China Registration ClassN/A

Develop Information

Active CompaniesCimeio Therapeutics AG
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A